957 related articles for article (PubMed ID: 8906828)
1. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
2. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
4. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.
Lagaudrière-Gesbert C; Lebel-Binay S; Wiertz E; Ploegh HL; Fradelizi D; Conjeaud H
J Immunol; 1997 Mar; 158(6):2790-7. PubMed ID: 9058814
[TBL] [Abstract][Full Text] [Related]
5. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
6. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
[TBL] [Abstract][Full Text] [Related]
7. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
8. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
[TBL] [Abstract][Full Text] [Related]
9. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
[TBL] [Abstract][Full Text] [Related]
10. Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.
Kozlowski S; Takeshita T; Boehncke WH; Takahashi H; Boyd LF; Germain RN; Berzofsky JA; Margulies DH
Nature; 1991 Jan; 349(6304):74-7. PubMed ID: 1985269
[TBL] [Abstract][Full Text] [Related]
11. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
12. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
13. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
Long EO; LaVaute T; Pinet V; Jaraquemada D
J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
[TBL] [Abstract][Full Text] [Related]
14. Peptide-induced conformational change of the class I heavy chain.
Elliott T; Cerundolo V; Elvin J; Townsend A
Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
[TBL] [Abstract][Full Text] [Related]
15. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
[TBL] [Abstract][Full Text] [Related]
16. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
17. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
Albert LJ; Ghumman B; Watts TH
J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
[TBL] [Abstract][Full Text] [Related]
18. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
Anderson KS; Alexander J; Wei M; Cresswell P
J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
[TBL] [Abstract][Full Text] [Related]
19. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
20. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
